↓ Skip to main content

Cell Biology and Translational Medicine, Volume 2

Overview of attention for book
Attention for Chapter 250: Potential Use of Stem Cells in Mood Disorders. - PubMed - NCBI
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 X user

Readers on

mendeley
22 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Potential Use of Stem Cells in Mood Disorders. - PubMed - NCBI
Chapter number 250
Book title
Cell Biology and Translational Medicine, Volume 2
Published in
Advances in experimental medicine and biology, July 2018
DOI 10.1007/5584_2018_250
Pubmed ID
Book ISBNs
978-3-03-004169-4, 978-3-03-004170-0
Authors

Colpo, Gabriela D, Stertz, Laura, Dinz, Breno S, Teixeira, Antonio L, Gabriela D. Colpo, Laura Stertz, Breno S. Diniz, Antonio L. Teixeira, Colpo, Gabriela D., Diniz, Breno S., Teixeira, Antonio L.

Abstract

Mood disorders are heterogeneous conditions characterized by complex genetics, unclear pathophysiology, and variable symptomatology. Currently, there is no biomarker for the diagnosis or prognosis of mood disorders, and the treatments are of limited efficacy in a significant proportion of patients. Furthermore, the disease models are not able to recapitulate their complexity. In this scenario, stem cells may have different applications in mood disorders. Circulating stem cells may be regarded as potential biomarkers. Mesenchymal stem cells are a promising therapeutic strategy for mood disorders as they promote neurogenesis and increase the expression of neurotrophic factors that enhance the survival and differentiation of neurons. In addition, induced pluripotent stem cells, cells reprogrammed from somatic cells of healthy subjects or patients, offer a great opportunity to recapitulate both normal and pathological development of human brain tissues, thereby opening a new avenue for disease modeling and drug development in a more disease-relevant system.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 22 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 22 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 3 14%
Student > Ph. D. Student 2 9%
Researcher 2 9%
Student > Bachelor 2 9%
Unknown 13 59%
Readers by discipline Count As %
Neuroscience 5 23%
Biochemistry, Genetics and Molecular Biology 2 9%
Psychology 1 5%
Unknown 14 64%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 July 2018.
All research outputs
#15,542,250
of 23,098,660 outputs
Outputs from Advances in experimental medicine and biology
#2,528
of 4,976 outputs
Outputs of similar age
#209,980
of 330,334 outputs
Outputs of similar age from Advances in experimental medicine and biology
#23
of 52 outputs
Altmetric has tracked 23,098,660 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,976 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.2. This one is in the 37th percentile – i.e., 37% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 330,334 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 28th percentile – i.e., 28% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 52 others from the same source and published within six weeks on either side of this one. This one is in the 38th percentile – i.e., 38% of its contemporaries scored the same or lower than it.